glp-1 agonists weight loss side effects Medications: Everything You Need to Know Curious about GLP-1 medications? They

About the fundamental differences between these medications helps explain why their effectiveness and side effect profiles vary so dramatically

Long-term studies confirmed that semaglutide supports sustained weight loss and improves physical and metabolic health, solidifying its role in managing obesity and related disorders (6)(23)

Abbreviations CVE: Cardiovascular event EHR: Electronic health record GLP-1RA: Glucagon-like peptide-1 receptor agonist MACE: Major adverse cardiovascular events NAFLD: Non-alcoholic fatty liver disease NASH: Non-alcoholic steatohepatitis PCI: Percutaneous coronary intervention PSM: Propensity score matching SGLT2: Sodiumglucose cotransporter 2 SMD: Standardised mean difference TG: Triacylglycerol References Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes

Studies published in JAMA Network confirm that bariatric surgery significantly reduces the risk of heart failure, stroke, and hypertension in obese individuals with Type 2 diabetes

If considering weight loss medication, it helps to understand the factors influencing your weight

Anti-inflammation and Anti-oxidation: the Key to unlocking the Cardiovascular potential of SGLT2 inhibitors and GLP1 receptor agonists